Contact Information
Company Information
Company
Cambrian Biopharma
Total Funding
216207003.0
Technologies
Gmail
Mimecast
Outlook
Google Apps
Amazon AWS
Mobile Friendly
Google Tag Manager
YouTube
MailChimp
IoT
Remote
AI
Keywords
biotech
longevity
longevity science
aging
aging biology
geroscience
healthspan
disease prevention
healthcare
pharma
innovation
science
biotechnology research
aging therapeutics
chronic diseases
preventive medicine
healthspan extension
clinical trials
ampk activators
metabolic disorders
oncology
cardiometabolic diseases
lifespan prolongation
clinical development
drug discovery
cell therapy advancements
research & development
age-related diseases
epigenetic therapies
fibrosis treatment
outcome-based medicine
medical research partnerships
drug efficacy trials
longevity research
mtor inhibitors
personalized medicine
translational medicine
biopharmaceutical product pipeline
nutrient metabolism
proteostasis
stem cell therapies
chronic inflammation
molecular aging
cellular rejuvenation
therapeutic innovation
targeted drug delivery
aging intervention
long-term health
human health modeling
scientific rigor
pharmaceutical r&d
tissue regeneration
predictive biomarkers
pharmacological therapies
gene therapy
healthcare ecosystem
clinical efficacy assessments
biotech venture capital
clinical-stage drug development
innovative medicines
transformative therapies
partnerships
therapeutics
fibrotic organs
ovarian function
women's health
amh/amr2 axis
pan-ampk activator
car-t cells
aging-related diseases
biopharmaceuticals
longevity therapeutics
chronic disease prevention
healthcare market
aging population
investors
biotech partners
collaborative innovation
therapeutic markets
molecular repair
cellular damage
aging-related conditions
competitive landscape
biotechnology
diagnostics
anti-aging therapeutics
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans